APP and Alzheimer disease: We therefore evaluated the beneficial effects of peripherally-administered HsTX1[R14A] in senescence accelerated murine prone 8 (SAMP8) mice, which exhibit memory deficits and cognitive decline in the absence of APP overexpression [26], thus closely mimicking what is observed in sporadic AD.